Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses and Food Effect of PRAX-562 in Healthy Volunteers

Next Previous
X
Search
Trial Profile

A Phase 1, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses and Food Effect of PRAX-562 in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Relutrigine (Primary)
  • Indications Epilepsy; Headache
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Praxis Precision Medicines

    • Most Recent Events

    • 31 Aug 2023 According to a Praxis Precision Medicines media release, data from this trial will be presented at the upcoming 35th International Epilepsy Congress (IEC) 2023.
    • 11 May 2023 According to a Praxis Precision Medicines media release, results findings from this trial presented in a poster presentation at the 75th Annual American Academy of Neurology (AAN) meeting in Apr 2023.
    • 27 Apr 2023 Results evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers, presented at the 75th Annual Meeting of the American Academy of Neurology 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top